BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30542506)

  • 1. Oncolytic properties of non-vaccinia poxviruses.
    Ricordel M; Foloppe J; Pichon C; Findeli A; Tosch C; Cordier P; Cochin S; Quémeneur E; Camus-Bouclainville C; Bertagnoli S; Erbs P
    Oncotarget; 2018 Nov; 9(89):35891-35906. PubMed ID: 30542506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccinia virus outperforms a panel of other poxviruses as a potent oncolytic agent for the control of head and neck squamous cell carcinoma cell lines.
    Nichols AC; Yoo J; Um S; Mundi N; Palma DA; Fung K; Macneil SD; Koropatnick J; Mymryk JS; Barrett JW
    Intervirology; 2014; 57(1):17-22. PubMed ID: 23942307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccinia Virus Shuffling: deVV5, a Novel Chimeric Poxvirus with Improved Oncolytic Potency.
    Ricordel M; Foloppe J; Antoine D; Findeli A; Kempf J; Cordier P; Gerbaud A; Grellier B; Lusky M; Quemeneur E; Erbs P
    Cancers (Basel); 2018 Jul; 10(7):. PubMed ID: 29996551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Enhanced Tumor Specificity of TG6002, an Armed Oncolytic Vaccinia Virus Deleted in Two Genes Involved in Nucleotide Metabolism.
    Foloppe J; Kempf J; Futin N; Kintz J; Cordier P; Pichon C; Findeli A; Vorburger F; Quemeneur E; Erbs P
    Mol Ther Oncolytics; 2019 Sep; 14():1-14. PubMed ID: 31011628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The control of anaplastic thyroid carcinoma cell lines by oncolytic poxviruses.
    Mundi N; Um S; Yoo J; Rizzo G; Black M; Pinto N; Palma DA; Fung K; MacNeil D; Mymryk JS; Barrett JW; Nichols AC
    Virus Res; 2014 Sep; 190():53-9. PubMed ID: 25038405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncolytic efficacy of thymidine kinase-deleted vaccinia virus strain Guang9.
    Deng L; Fan J; Ding Y; Zhang J; Zhou B; Zhang Y; Huang B
    Oncotarget; 2017 Jun; 8(25):40533-40543. PubMed ID: 28465492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cowpox Virus: A New and Armed Oncolytic Poxvirus.
    Ricordel M; Foloppe J; Pichon C; Sfrontato N; Antoine D; Tosch C; Cochin S; Cordier P; Quemeneur E; Camus-Bouclainville C; Bertagnoli S; Erbs P
    Mol Ther Oncolytics; 2017 Dec; 7():1-11. PubMed ID: 28951885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncolytic virotherapy with an armed vaccinia virus in an orthotopic model of renal carcinoma is associated with modification of the tumor microenvironment.
    Fend L; Remy-Ziller C; Foloppe J; Kempf J; Cochin S; Barraud L; Accart N; Erbs P; Fournel S; Préville X
    Oncoimmunology; 2016 Feb; 5(2):e1080414. PubMed ID: 27057460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical Evaluation of the Oncolytic Vaccinia Virus TG6002 by Translational Research on Canine Breast Cancer.
    Béguin J; Foloppe J; Maurey C; Laloy E; Hortelano J; Nourtier V; Pichon C; Cochin S; Cordier P; Huet H; Quemeneur E; Klonjkowski B; Erbs P
    Mol Ther Oncolytics; 2020 Dec; 19():57-66. PubMed ID: 33072863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted delivery of a suicide gene to human colorectal tumors by a conditionally replicating vaccinia virus.
    Foloppe J; Kintz J; Futin N; Findeli A; Cordier P; Schlesinger Y; Hoffmann C; Tosch C; Balloul JM; Erbs P
    Gene Ther; 2008 Oct; 15(20):1361-71. PubMed ID: 18480846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety studies and viral shedding of intramuscular administration of oncolytic vaccinia virus TG6002 in healthy beagle dogs.
    Béguin J; Nourtier V; Gantzer M; Cochin S; Foloppe J; Balloul JM; Laloy E; Tierny D; Klonjkowski B; Quemeneur E; Maurey C; Erbs P
    BMC Vet Res; 2020 Aug; 16(1):307. PubMed ID: 32843040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent oncolytic activity of raccoonpox virus in the absence of natural pathogenicity.
    Evgin L; Vähä-Koskela M; Rintoul J; Falls T; Le Boeuf F; Barrett JW; Bell JC; Stanford MM
    Mol Ther; 2010 May; 18(5):896-902. PubMed ID: 20160706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes.
    McCart JA; Ward JM; Lee J; Hu Y; Alexander HR; Libutti SK; Moss B; Bartlett DL
    Cancer Res; 2001 Dec; 61(24):8751-7. PubMed ID: 11751395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poxvirus Safety Analysis in the Pregnant Mouse Model, Vaccinia, and Raccoonpox Viruses.
    Roper RL
    Methods Mol Biol; 2017; 1581():121-129. PubMed ID: 28374246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel genetically modified oncolytic vaccinia virus in experimental models is effective against a wide range of human cancers.
    Haddad D; Chen N; Zhang Q; Chen CH; Yu YA; Gonzalez L; Aguilar J; Li P; Wong J; Szalay AA; Fong Y
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S665-74. PubMed ID: 22258815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumour activity of oncolytic Western Reserve vaccinia viruses in canine tumour cell lines, xenografts, and fresh tumour biopsies.
    Autio K; Knuuttila A; Kipar A; Ahonen M; Parviainen S; Diaconu I; Kanerva A; Hakonen T; Vähä-Koskela M; Hemminki A
    Vet Comp Oncol; 2016 Dec; 14(4):395-408. PubMed ID: 25302859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus.
    Kirn DH; Wang Y; Le Boeuf F; Bell J; Thorne SH
    PLoS Med; 2007 Dec; 4(12):e353. PubMed ID: 18162040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemovirotherapy of malignant melanoma with a targeted and armed oncolytic measles virus.
    Kaufmann JK; Bossow S; Grossardt C; Sawall S; Kupsch J; Erbs P; Hassel JC; von Kalle C; Enk AH; Nettelbeck DM; Ungerechts G
    J Invest Dermatol; 2013 Apr; 133(4):1034-42. PubMed ID: 23223133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Oncolytic Activity of a Double-Deleted Vaccinia Virus Copenhagen Strain against Malignant Pleural Mesothelioma.
    Delaunay T; Nader J; Grard M; Farine I; Hedwig V; Foloppe J; Blondy T; Violland M; Pouliquen D; Grégoire M; Boisgerault N; Erbs P; Fonteneau JF
    Mol Ther Oncolytics; 2020 Sep; 18():573-578. PubMed ID: 32995481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Oncolytic Virus Armed with Cancer Suicide Gene and Normal Vasculogenic Gene for Improved Anti-Tumor Activity.
    Jeong SN; Yoo SY
    Cancers (Basel); 2020 Apr; 12(5):. PubMed ID: 32344903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.